publication venue for
- Glioblastoma-induced inhibition of Langerhans cell differentiation from CD34(+) precursors is mediated by IL-6 but unaffected by JAK2/STAT3 inhibition.. 3. 2011
- Safety and stability of retrovirally transduced chimeric antigen receptor T cells.. 4. 2012
- Immunotherapies in transplantation and cancer: 22nd NAT meeting/2nd NAT LabEx IGO joint meeting; 1-2 June 2017, Nantes, France. 2017
- Six essential conditions for bladder-sparing strategies in bacillus Calmette-Guérin unresponsive bladder cancer.. 11. 2019
- Novel T-cell-based vaccines via arming polyclonal CD4+ T cells with antigen-specific exosomes.. 8. 2016
- Role of the crosstalk between CTLA-4 and NKG2D in the development of anti-CTLA-4 treatment strategies.. 5. 2013
- Cardiotoxicity with immune system targeting drugs: a meta-analysis of anti-PD/PD-L1 immunotherapy randomized clinical trials. 2019
- Chemotherapy-induced immunomodulation in non-small-cell lung cancer: a rationale for combination chemoimmunotherapy. 2017
- Vaccine strategies for the treatment of lymphoma: preclinical progress and clinical trial update. 2016
- Immune checkpoint inhibitor combinations in solid tumors: opportunities and challenges. 2016
- Alphavirus-based vaccines in melanoma: rationale and potential improvements in immunotherapeutic combinations. 2015
- Targeting castration-resistant prostate cancer with monoclonal antibodies and constructs. 2013
- Targeting cytotoxic T-lymphocyte antigen 4 in immunotherapies for melanoma and other cancers. 2010
- Update on intravesical agents for non-muscle-invasive bladder cancer. 2010
- Association between age and efficacy of first-line immunotherapy-based combination therapies for mRCC: a meta-analysis. 2023
- Low-dose or -number of BCG in non-muscle invasive bladder cancer: updated systematic review and meta-analysis. 2023
- Hematological prognosticators in metastatic renal cell cancer treated with immune checkpoint inhibitors: a meta-analysis. 2022
- Atherosclerosis: immunopathogenesis and strategies for immunotherapy. 2021
- Neoepitopes as cancer immunotherapy targets: key challenges and opportunities. 2017
- Algenpantucel-L immunotherapy in pancreatic adenocarcinoma. 2016
- Emerging targets in cancer immunotherapy: beyond CTLA-4 and PD-1. 2015
- CAR therapy for hematological cancers: can success seen in the treatment of B-cell acute lymphoblastic leukemia be applied to other hematological malignancies? 2015